Implementation of Fuzzy Tsukamoto Algorithm in Determining the Level of Financial Distress in Microfinance Institutions

Authors

  • Khairul  Faculty of Science and Technology, Universitas Pembangunan Panca Budi, Medan, Indonesia
  • A. P. U. Siahaan  Faculty of Science and Technology, Universitas Pembangunan Panca Budi, Medan, Indonesia
  • Mochammad Iswan Perangin-angin  Department of Informatics, STMIK Triguna Dharma, Medan, Indonesia
  • Andre Hasudungan Lubis  Faculty of Engineering, Universitas Medan Area, Medan, Indonesia
  • Sari Nuzullina Rahmadhani  Faculty of Economics and Business, Universitas Medan Area, Medan, Indonesia
  • Dahrul Siregar  Faculty of Economics and Business, Universitas Medan Area, Medan, Indonesia

DOI:

https://doi.org//10.32628/IJSRST1184113

Keywords:

Fuzzy Tsukamoto, Financial Distress, Microfinance Institutions

Abstract

Fuzzy Tsukamoto is one method that is very flexible and tolerant of existing data. Fuzzy Tsukamoto has the advantage of being more intuitive, accepted by many, more suitable for the input received from humans rather than machines. Microfinance institutions are specialized financial institutions established to provide business development services and community empowerment, either through loans or financing in micro-scale businesses to members and the community, deposit management, and the provision of business development consulting services that are not solely for profit. The purpose of this study is to apply the fuzzy Tsukamoto method to determine the level of financial distress in microfinance institutions in the city of Medan based on the variables Liquidity Ratio, Age Firm, and Cumulative Profitability Ratio, Profitability Ratio, Financial Structure Ratio, Capital Turnover Ratio.

References

  1. Berryman DE, Glad CA, List EO. Johannsson G. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013;9:346-356.
  2. Lewitt MS, Dent MS, Hall K. The insulin-like growth factor system in obesity, insulin resistance and type 2 diabetes mellitus. J Clin Med. 2014;3:1561-1574.
  3. Garten A, Schuster S, Kiess W. The insulin-like growth factors in adipogenesis and obesity. Endocrin Metab Clin. 2012;41:283-295, v-vi.
  4. Savastano S, Di Somma C, Barrea L, Colao A. The complex relationship between obesity and the somatropic axis: the long and winding road. Growth Horm IGF Res. 2014;24:221-226.
  5. Ren J, Anversa P. The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem Pharmacol. 2015;93:409-417.
  6. Ruderman NB, Schneider SH, Berchtold P. The 'metabolically-obese', normalweight individual. Am J Clin Nutr. 1981;34:1617-1621.
  7. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normalweight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care. 2004;27:2222-2228.
  8. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569-2575.
  9. Sparrow D, Borkan GA, Gerzof SG, Wisniewski C, Silbert CK. Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes. 1986;35:411-415.
  10. Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013;34:463-500.
  11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med. 2006;23:469-480.
  12. Li M, Gao Z, Ji D, Zhang S. Functional characterization of GH-like homolog in amphioxus reveals an ancient origin of GH/GH receptor system. Endocrinology. 2014;155:4818-4830.
  13. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997;18:801-831.
  14. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23:824-854.
  15. Livingstone C, Borai A. Insulin-like growth factor-II: its role in metabolic and endocrine disease. Clin Endocrinol (Oxf). 2014;80:773-781.
  16. Chia DJ. Minireview: mechanisms of growth hormone-mediated gene regulation. Mol Endocrinol. 2014;28:1012-1025.
  17. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30:152-177.
  18. Blundell TL, Humbel RE. Hormone families: pancreatic hormones and homologous growth factors. Nature. 1980;287:781-787.
  19. Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118:1786-1807.
  20. Berry DC, Stenesen D, Zeve D, Graff JM. The developmental origins of adipose tissue. Development. 2013;140:3939-3949.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2018-11-30

Issue

Volume 4, Issue 11, November-December-2018

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Khairul, A. P. U. Siahaan, Mochammad Iswan Perangin-angin, Andre Hasudungan Lubis, Sari Nuzullina Rahmadhani, Dahrul Siregar, " Implementation of Fuzzy Tsukamoto Algorithm in Determining the Level of Financial Distress in Microfinance Institutions, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 4, Issue 11, pp.09-15, November-December-2018. Available at doi : https://doi.org/10.32628/IJSRST1184113